David Bailey 

I am a consultant histopathologist and Clinical Lead for Cellular Pathology at North West Anglia NHS Foundation Trust (NWAngliaFT).

In my NHS consultant role, I have 27 years’ experience as a general histopathologist and an autopsy pathologist. I am the breast pathology lead for NWAngliaFT and was a founder member of the British Association of Urological Pathologists. I have previously published best practice guidance for prostate pathology and taught on FRCPath part 2 courses.  I introduced digital histopathology and AI-assisted reporting to the Trust, and since September 2024, have been NWAngliaFT site lead for the Ibex Galen Breast biopsy AI algorithm multi-centre UK implementation trial following a successful funding bid to NIHR.

I held several key positions at the Royal College of Pathologists including Vice President for Communications and International Affairs (2014-17) and Director of Training and Assessment (2010-14). I led pathology training and service development projects in Iraq, Pakistan, Sudan and sub-Saharan Africa. I was the lead author for the RCPath histopathology training curriculum (2010) and introduced stand-alone Certificates for Higher Autopsy and Cervical Cytology Training.

I have held posts as Clinical Director for the ME5 Pathology Network, Regional Clinical Lead for Pathology for NHS East of England, and director roles at NWAngliaFT for the Family and Integrated Support Services and General and Specialty Medicine Divisions.

My first consultant role was in Buckinghamshire where I spent 12 years as the training programme director for the Oxford Histopathology training programme, and five years as Associate Postgraduate Dean in the Oxford Deanery. I was also worked as a performance coach and mentor for the Deanery professional development unit which supported doctors in difficulty at all levels.

AI in pathology

The implementation of digital histopathology in laboratories around the UK has realised significant savings in pathologists’ time for reporting, as well as facilitating remote working and multicentre and multidisciplinary consultations.

The real potential of digital imaging in cellular pathology can only be realised however by the implementation of artificial intelligence algorithms which read the digital image files, highlight areas of interest, and potentially pre-order additional staining required for the pathologist to provide a comprehensive report.

This presentation documents our journey from the implementation of digital histopathology in 2020 to the current day, that sees us using AI to assist with the reporting of prostate and breast biopsies, including our involvement in the multicentre UK trial examining the implementation of the Ibex Galen Breast AI Algorithm within the NHS.


Managed and payment processed by: 

KC Jones conference&events Ltd
Telephone: 01332 227773
Email: bsbr@kc-jones.co.uk



Follow us on Social Media

Social Media Links